Veterinary Pharmaceuticals Global Market Report 2025

Description

Veterinary pharmaceuticals constitute a category of pharmacologically active drugs employed to control, prevent, and treat diseases in animals. These drugs exhibit their effects upon administration to animals and undergo rapid breakdown into active ingredients, primarily facilitated by small intestine metabolism.

The primary types of veterinary pharmaceuticals encompass veterinary vaccines, veterinary antibiotics, veterinary parasiticides, and other varieties. Veterinary vaccines offer protection against one or more diseases, mitigating their severity or preventing them altogether. The routes of administration include oral and various other routes tailored to different animal types, including companion animals and livestock. The vaccines themselves are classified into categories such as inactivated vaccines, attenuated vaccines, recombinant vaccines, and others, and they are supplied by diverse end-users, including veterinary hospitals, veterinary clinics, pharmacies, and drug stores.

The veterinary pharmaceuticals research report is one of a series of new reports from The Business Research Company that provides veterinary pharmaceuticals statistics, including veterinary pharmaceuticals industry global market size, regional shares, competitors with veterinary pharmaceuticals share, detailed veterinary pharmaceuticals segments, market trends and opportunities, and any further data you may need to thrive in the veterinary pharmaceuticals industry. This veterinary pharmaceuticals research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary pharmaceuticals market size has grown strongly in recent years. It will grow from $35.36 billion in 2024 to $37.87 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to increased pet population, the increased overall spending by individuals on pets, the growing penetration of e-commerce platforms promoting online pharmacies, the emerging markets growth, the increasing government initiatives and the increased disease prevalence.

The veterinary pharmaceuticals market size is expected to see strong growth in the next few years. It will grow to $50.59 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to the increasing pet ownership, the increasing population growth, the increasing disposable income, the increasing urbanization, the increasing penetration of pet insurance and the growing government support will drive the market. Major trends in the forecast period include focus on stem cell therapy to treat animals, focus on application of nanotechnology in veterinary medicines to tackle antibiotic resistance, development of chewable tablets, focus on use of telemedicine platforms to reduce the impact of COVID-19, development of advanced vaccines, focus on super-combo parasiticides, use of subunit and virus-like particle (VLP)-based vaccines and focus on strategic partnerships and collaborations.

The veterinary pharmaceuticals market is being driven by a notable increase in the prevalence rate of diseases among animals. The upsurge in disease incidence in both livestock and companion animals necessitates medicines for effective treatment. A significant example is the reported 79.7% increase in diabetes cases in dogs, from 13.1 cases per 10,000 to 23.6 cases, according to the Banfield State of Pet Health Report. This rise in disease prevalence underscores the heightened demand for veterinary pharmaceuticals.

The growing trend of pet ownership is anticipated to propel the growth of the veterinary pharmaceuticals market in the foreseeable future. Pet ownership involves the legal and ethical responsibility of individuals or households for the well-being of domesticated animals. As the number of pet owners increases, there is a corresponding rise in demand for specialized medications catering to various species, breeds, and health conditions. In 2023, a report from the American Pet Products Association Inc. revealed that 66% of US households owned pets, compared to 62% in 2022, with dogs being owned by 44.5% and cats by 29% of households in 2022. This surge in pet ownership is a key driver of the veterinary pharmaceuticals market.

Government agencies such as the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) regulate the veterinary pharmaceuticals market. Notably, the EU agencies require 6 to 12 months for the approval of veterinary medicinal products, and all parts of the registration dossier must be submitted together. In contrast, the US-FDA accepts phased submissions and assesses each technical section for 6 months. Efficient planning, effective communication, and careful consideration of regulatory policies are crucial for manufacturers in navigating the approval process and minimizing costs and timelines.

The emergence of generic drugs for animal care is a notable trend in the veterinary pharmaceuticals market. The cost-effectiveness of generic drugs has led to increased adoption by pet owners, with the FDA approving 22 generic animal drugs for cats and dogs. A survey of 520 veterinarians revealed that around 80% are using generic drugs to save pet owners money. Despite the lower profit margins compared to branded drugs, veterinarians are favoring generic drugs for their economic benefits.

Major companies in the veterinary pharmaceuticals market are innovating by introducing new products such as molidustat oral suspensions to expand customer bases and increase revenue. Elanco Animal Health Incorporated, for example, launched Varenzin-CA1 (molidustat oral suspension), the first medication for managing non-regenerative anemia in cats with chronic kidney disease (CKD). This needle-free oral suspension allows at-home administration, receiving provisional approval from the FDA. The unique features of Varenzin-CA1 showcase a commitment to providing novel therapies and expanding treatment options for animals with specific conditions or illnesses lacking effective treatments.

Major companies operating in the veterinary pharmaceuticals market include Zoetis Inc, Merck & Co., Inc, Boehringer Ingelheim International Gmb, Elanco Animal Health Incorporated, Ceva Sante Animale, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol S.A., Phibro Animal Health Corporation, Kyoritsu Seiyaku Corporation, Hebei Chengshengtang Animal Pharmaceutical, Shijiazhuang Fengqiang Animal Pharmaceutical Co,.Ltd, Vvaan Lifesciences Private Limited, Century Pharmaceuticals Limited, Cargill India Pvt. Ltd., Jurox Pty Ltd, Bayer, Veteq, Nimrod Veterinary Products Ltd., Bimeda, Orion Animal Health, Petmedix, Eco Animal Health, Teknofarma, Farmavet, Candioli Pharma, Suanfarma, Marino Ibericamed, MPA veterinary, Swetrade Pharmaceuticals AB, Animalcare, VET-AGRO Sp. z o. o, CANPOLAND SA, Cymedica, VIC Group, NITA-FARM, Apicenna LLC, Delos Medica, Provet Group, Bioveta AS, Veterinarski Zavod Subotica, PharmaGal s.r.o., Trifecta Pharmaceuticals USA LLC., Alberta Veterinary Laboratories Ltd., Veterinary Purchasing Co. Ltd, UCBVET, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, Lemavet, Primo Veterinary Medicines Trading LLC., AL Kubara Veterinary Medicines Trading LLC., Eurovets Veterinary Suppliers, Saudi Pharmaceutical Industries, DBK Pharma S.A.E., Dawa Limited, Neimeth International Pharmaceuticals, Osy-Adamu Pharmaceutical Co., Global Vet (U) Ltd

North America was the largest region in the veterinary pharmaceuticals market in 2024. Asia-Pacific was the second-largest region in the global veterinary pharmaceuticals market report. The regions covered in the veterinary pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the veterinary pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The veterinary pharmaceuticals market consists of sales of biological drugs, biosimilars, monoclonal antibodies, sedatives, and antihistaminic. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Pharmaceuticals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary pharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary pharmaceuticals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary pharmaceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Other Veterinary Pharmaceuticals
2) By Type Of Animal: Livestock, Companion Animals
3) By Type Of Vaccine: Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines, Other Vaccines
4) By Route Of Administration: Oral, Parenteral, Topical, Other Routes Of Administration
5) By End User: Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores
Subsegments:
1) By Veterinary Vaccines: Inactivated Vaccines; Live Attenuated Vaccines; Recombinant Vaccines; DNA Vaccines; Subunit Vaccines
2) By Veterinary Antibiotics: Penicillins; Cephalosporins; Tetracyclines; Fluoroquinolones; Macrolides
3) By Veterinary Parasiticides: Endoparasiticides; Ectoparasiticides; Endectocides; Antiprotozoals
4) By Other Veterinary Pharmaceuticals: Anti-inflammatory Drugs; Analgesics; Hormonal Medications; Antifungals
Companies Mentioned: Zoetis Inc; Merck & Co., Inc; Boehringer Ingelheim International Gmb; Elanco Animal Health Incorporated; Ceva Sante Animale
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r26026

1. Executive Summary

2. Veterinary Pharmaceuticals Market Characteristics

3. Veterinary Pharmaceuticals Market Trends And Strategies

4. Veterinary Pharmaceuticals Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Veterinary Pharmaceuticals Growth Analysis And Strategic Analysis Framework

5.1. Global Veterinary Pharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Veterinary Pharmaceuticals Market Growth Rate Analysis
5.4. Global Veterinary Pharmaceuticals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Veterinary Pharmaceuticals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Veterinary Pharmaceuticals Total Addressable Market (TAM)

6. Veterinary Pharmaceuticals Market Segmentation

6.1. Global Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Veterinary Vaccines
Veterinary Antibiotics
Veterinary Parasiticides
Other Types
6.2. Global Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Companion Animals
Livestock Animals
6.3. Global Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inactivated Vaccines
Attenuated Vaccines
Recombinant Vaccines
6.4. Global Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Other Routes Of Administration
6.5. Global Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Veterinary Hospitals
Veterinary Clinics
Pharmacies And Drug Stores
6.6. Global Veterinary Pharmaceuticals Market, Sub-Segmentation Of Veterinary Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inactivated Vaccines
Live Attenuated Vaccines
Recombinant Vaccines
DNA Vaccines
Subunit Vaccines
6.7. Global Veterinary Pharmaceuticals Market, Sub-Segmentation Of Veterinary Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Penicillins
Cephalosporins
Tetracyclines
Fluoroquinolones
Macrolides
6.8. Global Veterinary Pharmaceuticals Market, Sub-Segmentation Of Veterinary Parasiticides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Endoparasiticides
Ectoparasiticides
Endectocides
Antiprotozoals
6.9. Global Veterinary Pharmaceuticals Market, Sub-Segmentation Of Other Veterinary Pharmaceuticals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Anti-inflammatory Drugs
Analgesics
Hormonal Medications
Antifungals

7. Veterinary Pharmaceuticals Market Regional And Country Analysis

7.1. Global Veterinary Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Veterinary Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Veterinary Pharmaceuticals Market

8.1. Asia-Pacific Veterinary Pharmaceuticals Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Veterinary Pharmaceuticals Market

9.1. China Veterinary Pharmaceuticals Market Overview
9.2. China Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Veterinary Pharmaceuticals Market

10.1. India Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Veterinary Pharmaceuticals Market

11.1. Japan Veterinary Pharmaceuticals Market Overview
11.2. Japan Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Veterinary Pharmaceuticals Market

12.1. Australia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Veterinary Pharmaceuticals Market

13.1. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Veterinary Pharmaceuticals Market

14.1. South Korea Veterinary Pharmaceuticals Market Overview
14.2. South Korea Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Veterinary Pharmaceuticals Market

15.1. Western Europe Veterinary Pharmaceuticals Market Overview
15.2. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Veterinary Pharmaceuticals Market

16.1. UK Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Veterinary Pharmaceuticals Market

17.1. Germany Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Veterinary Pharmaceuticals Market

18.1. France Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Veterinary Pharmaceuticals Market

19.1. Italy Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Veterinary Pharmaceuticals Market

20.1. Spain Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Veterinary Pharmaceuticals Market

21.1. Eastern Europe Veterinary Pharmaceuticals Market Overview
21.2. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Veterinary Pharmaceuticals Market

22.1. Russia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Veterinary Pharmaceuticals Market

23.1. North America Veterinary Pharmaceuticals Market Overview
23.2. North America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Veterinary Pharmaceuticals Market

24.1. USA Veterinary Pharmaceuticals Market Overview
24.2. USA Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Veterinary Pharmaceuticals Market

25.1. Canada Veterinary Pharmaceuticals Market Overview
25.2. Canada Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Veterinary Pharmaceuticals Market

26.1. South America Veterinary Pharmaceuticals Market Overview
26.2. South America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Veterinary Pharmaceuticals Market

27.1. Brazil Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Veterinary Pharmaceuticals Market

28.1. Middle East Veterinary Pharmaceuticals Market Overview
28.2. Middle East Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Veterinary Pharmaceuticals Market

29.1. Africa Veterinary Pharmaceuticals Market Overview
29.2. Africa Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Veterinary Pharmaceuticals Market Competitive Landscape And Company Profiles

30.1. Veterinary Pharmaceuticals Market Competitive Landscape
30.2. Veterinary Pharmaceuticals Market Company Profiles
- 30.2.1. Zoetis Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co., Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Boehringer Ingelheim International Gmb Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Ceva Sante Animale Overview, Products and Services, Strategy and Financial Analysis

31. Veterinary Pharmaceuticals Market Other Major And Innovative Companies

31.1. Virbac SA
31.2. Dechra Pharmaceuticals PLC
31.3. Vetoquinol S.A.
31.4. Phibro Animal Health Corporation
31.5. Kyoritsu Seiyaku Corporation
31.6. Hebei Chengshengtang Animal Pharmaceutical
31.7. Shijiazhuang Fengqiang Animal Pharmaceutical Co., Ltd
31.8. Vvaan Lifesciences Private Limited
31.9. Century Pharmaceuticals Limited
31.10. Cargill India Pvt. Ltd.
31.11. Jurox Pty Ltd
31.12. Bayer
31.13. Veteq
31.14. Nimrod Veterinary Products Ltd.
31.15. Bimeda

32. Global Veterinary Pharmaceuticals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Pharmaceuticals Market

34. Recent Developments In The Veterinary Pharmaceuticals Market

35. Veterinary Pharmaceuticals Market High Potential Countries, Segments and Strategies

35.1 Veterinary Pharmaceuticals Market In 2029 - Countries Offering Most New Opportunities
35.2 Veterinary Pharmaceuticals Market In 2029 - Segments Offering Most New Opportunities
35.3 Veterinary Pharmaceuticals Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer